Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer-Reference-Cited by-同舟云学术

Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer

Published:1996-11 Issue:9037 Volume:348 Page:1279-1281
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Basser Russell L,Rasko John EJ,Clarke Kerrie,Cebon Jonathan,Green Michael D,Hussein Sonay,Alt Carole,Menchaca Dora,Tomita Dianne,Marty Jenny,Fox Richard M,Begley C Glenn

Publisher

Elsevier BV

Subject

General Medicine

Reference23 articles.

1. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo;Lok;Nature,1994

2. Purification and characterization of thrombopoietin;Kato;J Biochem (Tokyo),1995

3. Stimulation of megakaryopoiesis and thrombopoiesis by the c-mpl ligand;de Sauvage;Nature,1994

4. c-mpl ligaild is a humoral regulator of megakaryopoiesis;Wendling;Nature,1994

5. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor mpl;Bartley;Cell,1994

Cited by 204 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune thrombocytopenia (ITP): historical perspectives, pathophysiology, and treatment advances;Discover Medicine;2024-07-02

2. Eltrombopag in pediatric chronic and refractory ITP: data from a retrospective multicenter study from Lebanon;Annals of Hematology;2022-03-12

3. Thrombopoietin Receptor Agonists;Platelets;2019

4. Immune Thrombocytopenia (ITP);Platelets;2019

5. Eltrombopag for use in children with immune thrombocytopenia;Blood Advances;2018-02-27